Find the right fit for you - faster
Get tailored insights about working at Bracco in one quick step.
Bracco Snapshot
Bracco Diagnostics Inc. specializes in the clinical development, marketing and sales of diagnostic contrast imaging agents. Bracco Diagnostics Inc. primarily markets its products to hospitals throughout the United States. We committed to the discovery, development, manufacturing and marketing of imaging agents and solutions aimed at providing a better use and management in terms of diagnostic efficacy, patient safety and cost effectiveness. Bracco Diagnostics Inc is part of the Bracco Group, an international Group headquartered in Milan, Italy and active in the healthcare sector and a leader in diagnostic imaging. It has around 4,000 employees and annual total consolidated revenues of around 2 billion euros, 89% of which are from international sales. In the R&D area, the company invests approximately 10% of reference turnover in the imaging diagnostics and medical devices sectors. The Group’s main products are contrast agents, medical substances used to improve the diagnostic accuracy of biomedical imaging and the care of patients affected by diseases of varying type and severity. Bracco offers an extensive and innovative portfolio of products and solutions for all diagnostic modalities completed by several medical devices and advanced administration systems for contrast imaging products in the fields of cardiology and radiology. The Company operates in over 110 markets globally
